Neptune to Hold Conference Call to Discuss Third Quarter Results for the Period Ended November 30, 2

Neptune to Hold Conference Call to Discuss Third Quarter Results for the Period Ended November 30, 2016

ID: 515749

(firmenpresse) - LAVAL, QUEBEC -- (Marketwired) -- 01/04/17 -- Neptune Technologies & Bioressources Inc. ("Neptune" or the "Company") (NASDAQ: NEPT)(TSX: NEPT), announces that it will be holding a conference call on January 12, 2017 at 5:30 PM (EST) to discuss its third quarter results for the period ended November 30, 2016.

The third quarter results press release will be issued after markets close on the same day.

Conference Call Details:

Webcast: A live audio webcast and presentation of the results can be accessed at:

A replay of the call will be available for replay two hours after the call's completion, until February 12, 2017. The telephone numbers to access the replay of the call are 1 (416) 621-4642 or 1 (800) 585-8367 (toll-free), Conference ID 39042107. The archive of the webcast, along with its accompanying presentation, will also be made available immediately in the Investors section of Neptune's website under Investor Events and Presentations.

About Neptune Technologies & Bioressources Inc.

Neptune is a nutrition products company focused on the business of customized unique nutrition solutions, specialty ingredients and consumer brands. The company develops turnkey solutions available in various unique delivery forms. Neptune also offers premium krill oil manufactured in its state-of-the art facility and a variety of other specialty ingredients such as marine and seed oils. Neptune sells its premium krill oil under the OCEANO3® brand directly to consumers in Canada and the United States through web sales at . OCEANO3 is also sold as a turnkey solution to distributors. The Company's head office is located in Laval, Quebec.

Neptune is also pursuing opportunities in the prescription drug markets, through its approximately 48% owned subsidiary Acasti Pharma Inc. ("Acasti"). Acasti focuses on the research, development and commercialization of new krill oil-based forms of omega-3 phospholipid therapies for the treatment of severe hypertriglyceridemia.





SOURCE: Neptune Technologies & Bioressources Inc.



Contacts:
Mario Paradis
VP & CFO
1 (450) 687-2262



James Carbonara
Hayden IR
1 (646) 755-4712


Pierre Boucher
MaisonBrison
1 (514) 731-0000

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Advantis Corp. Acquires Large Commercial Space Arch Therapeutics to Present at The Biotech Showcase(TM) 2017 Conference on January 10th, 2017
Bereitgestellt von Benutzer: Marketwired
Datum: 04.01.2017 - 13:30 Uhr
Sprache: Deutsch
News-ID 515749
Anzahl Zeichen: 0

contact information:
Town:

LAVAL, QUEBEC



Kategorie:

Alternative



Diese Pressemitteilung wurde bisher 178 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Neptune to Hold Conference Call to Discuss Third Quarter Results for the Period Ended November 30, 2016"
steht unter der journalistisch-redaktionellen Verantwortung von

Neptune Technologies & Bioressources Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Neptune Announces Second Quarter Results ...

LAVAL, QUEBEC -- (Marketwired) -- 11/14/17 -- Q2 Financial and Operational Highlights for the 3-month period ended September 30, 2017 compared to the 3-month period ended August 31, 2016(1)Post Quarter End Highlights:Neptune Technologies & Biore ...

Alle Meldungen von Neptune Technologies & Bioressources Inc.



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z